Related Experiment Video
Updated: Aug 11, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Ablative therapy for atrioventricular nodal reentry arrhythmias
1Division of Cardiology and Medicine, Northwestern Memorial Hospital, Chicago, IL.
Radiofrequency ablation effectively treats atrioventricular (AV) nodal reentry by targeting the slow pathway near the coronary sinus. This curative technique offers high success rates for patients with drug-resistant AV nodal reentry.
Area of Science:
- Clinical electrophysiology
- Cardiac electrophysiology
- Cardiology
Background:
- Recent studies have improved understanding of the atrioventricular (AV) junction's physiologic anatomy.
- This knowledge aids in developing curative techniques for AV nodal (junctional) reentry.
Purpose of the Study:
- To describe advancements in understanding AV junctional anatomy.
- To detail curative techniques for AV nodal reentry, focusing on slow pathway ablation.
Main Methods:
- Identifying distinct locations for slow and fast pathways in AV nodal reentry.
- Utilizing radiofrequency ablation targeting the slow pathway near the coronary sinus ostium.
Main Results:
- The slow pathway is typically located caudal to the AV node near the coronary sinus os.
- The fast pathway is generally found along the anterior tricuspid annulus.
- Radiofrequency ablation of the slow pathway achieves >95% primary success, with <2% complications and 5-10% recurrence.
Conclusions:
- Physiologic heterogeneity of the AV junction enables curative AV nodal reentry treatment.
- Radiofrequency ablation of the slow pathway is a highly effective and safe treatment.
- AV nodal modification is a reasonable primary therapy for AV nodal reentry across all age groups.
More Related Videos
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias